Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 80174 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
XW03396
|
Introduction of Ceftolozane/Tazobactam Anti-infective into Peripheral Vein Percutaneous Approach New Technology Group 6
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW03398
|
Introduction of Inebilizumab-cdon into Peripheral Vein Percutaneous Approach New Technology Group 8
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW0339A
|
Introduction of Odronextamab Antineoplastic into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033A7
|
Introduction of Ciltacabtagene Autoleucel into Peripheral Vein Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033B3
|
Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Peripheral Vein Percutaneous Approach New Technology Group 3
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033BA
|
Introduction of Orca-T Allogeneic T-cell Immunotherapy into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033C7
|
Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033CA
|
Introduction of Zanidatamab Antineoplastic into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033DA
|
Introduction of Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033E5
|
Introduction of Remdesivir Anti-infective into Peripheral Vein Percutaneous Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033F3
|
Introduction of Other New Technology Therapeutic Substance into Peripheral Vein Percutaneous Approach New Technology Group 3
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033F5
|
Introduction of Other New Technology Therapeutic Substance into Peripheral Vein Percutaneous Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033FA
|
Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Peripheral Vein Percutaneous Approach New Technology Group 10
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033FB
|
Introduction of Valoctocogene Roxaparvovec-rvox into Peripheral Vein Percutaneous Approach New Technology Group 11
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033G5
|
Introduction of Sarilumab into Peripheral Vein Percutaneous Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033G6
|
Introduction of REGN-COV2 Monoclonal Antibody into Peripheral Vein Percutaneous Approach New Technology Group 6
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033G7
|
Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Peripheral Vein Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033H5
|
Introduction of Tocilizumab into Peripheral Vein Percutaneous Approach New Technology Group 5
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033H6
|
Introduction of Other New Technology Monoclonal Antibody into Peripheral Vein Percutaneous Approach New Technology Group 6
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
XW033H7
|
Introduction of Axicabtagene Ciloleucel Immunotherapy into Peripheral Vein Percutaneous Approach New Technology Group 7
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.